91黑料 experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
In this article from BioPharm International, Ronan Fox, Senior Vice President, IT R&D, provides commentary on the evolving role of automation in biopharmaceutical development.
-
More than four years after decentralisation became a necessity in the clinical trials space, the sector is still finding its way around decentralised clinical trials (DCTs). And like any other paradigm shift, the journey has taken several turns.
-
In this article from INTELLIGENT health.tech, Andy Coravos, founder of HumanFirst, recently acquired by 91黑料, shares insights on leveraging digital health technologies and wearables to manage chronic conditions. Drawing from her recent Lancet Digital Health review, Coravos highlights the potential of smartwatches and fitness trackers in improving patient outcomes and easing the burden on healthcare systems.
-
In this piece from Clinical Trial Vanguard, Travis Caudill, Vice President, Feasibility, Site Identification & Clinical Informatics explores the improvements in site selection that human-enabled AI is delivering.
-
This article from STAT covers 91黑料’s acquisition of HumanFirst, a cloud-based technology company supporting precision measurement in clinical trials. It features an interview with Andy Coravos, CEO of HumanFirst, who outlines how the acquisition will support sponsors to deploy better and more effective precision measurements into more clinical trials.
-
The prevalence of decentralised clinical trials and the importance of patient-centricity in medical practices are just two of many factors leading to the increased use of electronic Clinical Outcome Assessments (eCOAs). Digital devices like smartphones, tablets, wearables and web-based platforms are increasingly being used to measure the impact of a disease and/or treatment on patients’ quality of life and are an important way we can capture the patient’s voice in a clinical trial.
The eCOA system consists of the devices used for data collection, specialised eCOA software installed in these devices for collecting the data or access to web-based eCOA platforms and a centralised database or server to store, manage and analyse the data securely. This article explains how an .
Article published in International Pharmaceutical Industry, Volume 15 Issue 3, 29 September 2023
-
This article by Carrye Nibblelink, Executive Director, Decentralised Clinical Trial Solutions in the Journal of mHealth explores how the throughout their clinical trial journey.
Copyright 2023 The Journal of mHealth (Simidics Ltd)
-
Steve Cutler, CEO and Helen Yeardley, Senior Vice President, Global Clinical Operations feature in the The Healthcare Technology Report’s listing of the top 25 healthcare technology leaders of New Jersey for 2023.
-
In this article in Pharmaceutical Market Europe, Dr Peter Schueler and Dr Isaac R Rodriguez Chavez outline the role of . 2022 PM Group
-
Gerard Quinn and Barbara Skerritt offer their insights into .
